BSE filing, NSE: CORALAB. Summary written from the filing by ALFA Finder's alert engine.
Coral Laboratories Ltd: key numbers
- Share price
- ₹498.00
- Market cap
- ₹177.9 Cr
- Revenue (annual)
- ₹85.90 Cr
- Net profit (annual)
- ₹16.38 Cr
- P/E (TTM)
- 9.3×Sector 43.0×
- Promoter holding
- 71.51%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Coral Laboratories Ltd
All →Coral Laboratories Board Meeting Date
Coral Laboratories will hold a board meeting on 14 Nov 2026 to consider unaudited standalone half-yearly results for the period ended September 2026, plus other business. Trading window closes from 1 Oct to 16 Nov 2026.
Coral Laboratories Other Announcement
The company has filed its quarterly shareholding pattern statement for the quarter ended September 30, 2026, as required under SEBI Regulation 31.
Coral Laboratories Annual General Meeting
Coral Laboratories Limited held its 44th Annual General Meeting on September 29, 2026. Shareholders approved the FY2025-26 audited financial statements, declared a final dividend, and re-appointed retiring directors.
Coral Laboratories Board Meeting Outcome
Coral Laboratories Ltd's board approved the Cost Audit Report for fiscal year 2025-26. This routine meeting involved no other material financial or business decisions.
Coral Laboratories Board Meeting Date
Coral Laboratories intimated BSE of a board meeting scheduled for 25 September 2026. The agenda includes approval of the cost audit report for FY 2025-26.
Coral Laboratories Annual General Meeting
Coral Laboratories Limited has issued a notice for its Annual General Meeting scheduled for June 29, 2026. Agenda items include adoption of financial statements and dividend declaration.
Other annual general meeting announcements
All →Meesho Annual General Meeting
Meesho seeks postal ballot approval, with voting closing 08-Dec-2026, to appoint Sudhir Sitapati as Independent Director. The resolution also covers ₹1 Crore annual remuneration.
Indrayani Biotech Annual General Meeting
Indrayani Biotech's 34th AGM is set for 30 November 2026, with book closure from 24 to 30 November. Remote e-voting runs 27 to 29 November 2026.
Kirloskar Ferrous Industries Annual General Meeting
Kirloskar Ferrous shareholders approved Ajay Shriram Patil's appointment as Director and Joint Managing Director via postal ballot. Both ordinary resolutions passed with over 98% votes in favour.
Gland Pharma Annual General Meeting
Gland Pharma's shareholders approved the appointment of Xingli Wang as Non-Executive Non-Independent Director via postal ballot. The ordinary resolution passed with 97.07% of votes in favour.
HDFC Bank Annual General Meeting
HDFC Bank's postal ballot passed the appointment of Anup Bagchi as Managing Director and CEO. Approval was deemed on 6 November 2026 with 98.646% votes in favour.
Britannia Industries Annual General Meeting
Britannia shareholders passed the special resolution appointing Sonny Iqbal as Non-Executive Independent Director via postal ballot. Approval was 99.7187% in favour of votes polled.